Lumentum falls 19% as Marvell's slide cuts its takeover value
Why is Lumentum stock down today?
Marvell agreed to buy Lumentum, an optical-components maker, paying 4.5 Marvell shares for each Lumentum share. Because the price is set in Marvell shares, the offer was worth $771 at Monday's close, down from about $1,132 when Marvell's stock was higher. Lumentum fell 18.6% to $684.40, 11% below even that.
What it means
- What changed
- Lumentum's price now tracks Marvell's: each share is set to become 4.5 Marvell shares, if both companies' stockholders and regulators approve.
- What hasn't changed
- Lumentum's business kept growing: quarterly revenue more than doubled to $1.26 billion, and it forecast about $1.6 billion for the next quarter.
- Next · Not yet scheduled
- The joint registration statement (Form S-4) with the proxy for both stockholder votes; closing is expected in the first half of 2028.
- Move
- ▼ 18.6%
- Price
- $840.70 → $684.40
- Value lost
- ~$14.0B
- Offer per share
- 4.5 Marvell shares
- Offer value at close
- $771 (was ~$1,132)
- Gap below offer
- 11.3% (4.9% Friday)
Prices: Nasdaq historical close, Nov 2, 2026 · Company data: 10-K, Jun 27, 2026 · What these numbers mean
Official Nasdaq closing prices: $840.70 on Oct 30 and $684.40 on Nov 2, 2026 (Yahoo Finance and CNBC show the same). Marvell: $196.40 and $171.41.
Snapshot at the Nov 2, 2026 close
- Market value
- $61.4B
- Enterprise value
- $60.3B
- Price/sales
- 20.4×
- EV/sales
- 20.0×
- P/E
- n/m
- Price/FCF
- 204.6×
- Revenue growth
- +83%
- FCF margin
- 10%
- Net cash
- $1.1B
Our calculation from the company's filings (latest: 10-K for the fiscal year to Jun 27, 2026, filed Aug 17, 2026); not investment advice. Revenue, earnings and cash flow: FY2026 (year to Jun 27, 2026). Price $684.40 (Nasdaq historical close); 89.7 million shares (common shares on the cover page of the 10-K filed Aug 17, 2026). n/m = not meaningful (e.g. negative earnings).
What happened
Lumentum’s stock fell 18.6% on Monday, when Marvell Technology announced an agreement to buy it in an all-stock deal. The S&P 500 fell 0.5% and the Nasdaq Composite 1.1%.
- Lumentum makes lasers and devices that send, receive and route data using light, used in AI data centers and telecom networks. Marvell makes chips that connect equipment in data centers, according to the companies.
- The two companies announced the deal before the market opened on Monday, Nov 2. Lumentum stockholders are to receive 4.500 Marvell shares for each Lumentum share, with cash for fractions. The agreement was signed on Nov 1.
- The companies valued the deal at $115 billion including debt, or about $1,132 a Lumentum share. That figure uses Oct 28 closing prices, which they called the last day before market speculation began, and is a 23.9% premium to Lumentum’s price that day.
- Lumentum closed at $684.40, down $156.30, per Nasdaq. Based on the 89.7 million shares on the cover of its latest annual report, that is about $14.0 billion of market value lost, by our calculation. Marvell closed at $171.41, down 12.7%.
- Lumentum also reported results for its fiscal first quarter on Monday. Revenue rose 136.5% from a year earlier to $1.26 billion. Adjusted earnings per share (EPS) of $4.57 beat the $4.21 consensus, and its forecast of about $1.6 billion for its fiscal second quarter was above the $1.48 billion analysts expected, the Motley Fool reported.
Why the market reacted this way
The price was fixed in Marvell shares, and Marvell’s stock had already fallen for three sessions. On Monday, Lumentum also slipped further below the value of the offer.
What Lumentum holders get, and what it is worth
Each Lumentum share is set to become 4.5 Marvell shares. The number is fixed, so the dollar value of the offer moves with Marvell’s price; the 8-K describes no floor or cap on that value.
| Marvell close | Marvell price | Offer value per Lumentum share (4.5 × Marvell) | Lumentum close | Lumentum vs offer value |
|---|---|---|---|---|
| Oct 28 (before the reports) | $251.65 | $1,132.43 | $913.95 | 19.3% below |
| Oct 30 (Friday) | $196.40 | $883.80 | $840.70 | 4.9% below |
| Nov 2 (Monday) | $171.41 | $771.35 | $684.40 | 11.3% below |
Prices are Nasdaq closes; the offer values and gaps are our calculation.
- Bloomberg reported after the close on Oct 28 that Marvell was in advanced talks to buy Lumentum, probably with stock, the Motley Fool reported. Marvell fell 13.2% the next day and another 10.0% on Friday.
- Over the three sessions to Monday, Marvell fell 31.9%, and the offer’s value fell by the same 31.9%, from about $1,132 to $771 a Lumentum share, by our calculation.
- At Monday’s close, the offer was worth less than Lumentum’s own price of $913.95 on Oct 28, before the reports.
Why the target fell more than the buyer
Lumentum fell 18.6%, compared with Marvell’s 12.7% decline, and its discount to the value of the promised Marvell shares widened.
- On Friday, Lumentum traded 4.9% below the value of 4.5 Marvell shares. On Monday it closed 11.3% below, a gap of about $87 a share.
- If the gap had stayed at Friday’s 4.9%, Lumentum would have fallen about as much as Marvell, to about $733.73. Its actual close was 6.7% below that level, equal to 5.9 percentage points of Friday’s close, by our calculation.
- The companies expect closing in the first half of 2028, subject to stockholder and regulatory approvals. These conditions create uncertainty, but they do not establish why the discount widened on Monday, and we found no report that does.
The conditions and the timing, from the merger 8-K
- Lumentum’s stockholders must adopt the agreement. Marvell’s stockholders must approve issuing the new shares and raising the number of shares Marvell is allowed to issue.
- The US antitrust waiting period (under the Hart-Scott-Rodino Act) must end, and other “required regulatory approvals” must be received. The 8-K summary does not identify their jurisdictions; the merger agreement refers to a list in Marvell’s disclosure letter, which was not filed.
- Either company can generally terminate the agreement if the deal has not closed by Nov 1, 2027. That date extends automatically in stages to Feb 1, May 1 and Aug 1, 2028 if specified regulatory conditions remain unresolved and the other closing conditions are met.
- The agreement sets fees for specified terminations. If Marvell’s board withdraws its support, or Marvell takes a better offer, Marvell pays Lumentum $5.8 billion. Lumentum would pay $2.9 billion in the matching cases. Marvell pays a $3.2 billion fee in certain cases where the deal fails over regulatory approvals.
- After closing, Marvell’s current holders would own about 67% of the combined company and Lumentum’s about 33%, on a fully diluted basis. Marvell CEO Matt Murphy would lead it, and three Lumentum directors, including CEO Michael Hurlston, would join Marvell’s board.
Why Marvell’s holders sold
- The companies said the deal should bring more than $1 billion of yearly cost savings and add to Marvell’s adjusted EPS in the first year after closing.
- William Blair said investors weighed the larger product range against dilution and integration risk, and expects the deal to be the focus of investor concerns in the coming quarters, Investing.com reported. It kept its Outperform rating on Marvell.
Does this change Lumentum’s future?
What did NOT change
- Lumentum reported revenue growth of 25.5% from the previous quarter, and the company forecast $1.575–1.625 billion for its fiscal second quarter.
- Lumentum remains an independent, listed company until the deal closes, and the agreement can still fail.
What DID change
- Lumentum’s share price now depends mostly on Marvell’s share price and on the odds and timing of closing, not only on its own results.
- A competing bid would be costly: Lumentum would owe Marvell $2.9 billion if it left the deal for a better offer.
Our read
For Lumentum holders, the headline value of $1,132 a share is no longer the offer. What they are set to receive is 4.5 Marvell shares, whose value changes daily, after a wait of more than a year. Lumentum traded below the current value of those shares; the deal remains subject to approvals, and that value can change before closing.
The other view
Lumentum CEO Michael Hurlston said joining Marvell creates a company positioned for a $550 billion market that can generate "significant, sustainable stockholder value"; Lumentum holders would own about 33% of it.
What to watch next
- Not yet scheduled
- The Form S-4 registration statement with the joint proxy, which sets up votes by both companies' stockholders. Marvell's holders must approve issuing the new shares.
- Nov 1, 2027 (outside date)
- Either side may generally terminate if the deal has not closed; the date extends automatically, up to Aug 1, 2028, if specified regulatory conditions remain unresolved.
- First half of 2028 (expected)
- Closing, after US antitrust clearance and other required regulatory approvals, whose jurisdictions the 8-K summary does not identify.
Quick questions
What do Lumentum shareholders get in the Marvell deal?
4.5 Marvell shares for each Lumentum share, with cash for any fraction of a share. The number of shares is fixed, so the value moves with Marvell's stock price until the deal closes.
What is a fixed exchange ratio?
A takeover price set in the buyer's shares rather than in dollars. If the buyer's stock falls, the offer is worth less, and the target's stock usually falls with it.
Why does Lumentum trade below the offer value?
The deal is not expected to close until the first half of 2028 and needs approval from both companies' stockholders and from regulators. Buyers of Lumentum today take that wait and the risk that the deal fails.
About Lumentum: Website (external site)Investor relations (external site)SEC filings (external site)Wikipedia (external site)
+ 7 more
Accessed Nov 2, 2026: Motley Fool: Why Lumentum stock fell 14.9% today · Motley Fool: Why Marvell stock is down today (Oct 29) · Investing.com: William Blair reiterates Outperform on Marvell · Marvell merger agreement (Exhibit 2.1) · Yahoo Finance: S&P 500 and Nasdaq Composite closes · Lumentum 10-K FY2026 (cover share count) · Nasdaq: LITE and MRVL historical prices
Quoting this? You may quote short excerpts under our reuse policy. Please credit WhyMyStockMoved.com and link to this page.